Valentina Orlando1,2, Federico Rea3,4, Laura Savaré3,4, Ilaria Guarino1, Sara Mucherino1,2, Alessandro Perrella5, Ugo Trama6, Enrico Coscioni7, Enrica Menditto1,2, Giovanni Corrao3,4. 1. CIRFF, Center of Drug Utilization and Pharmacoeconomics, University of Naples Federico II, Naples, Italy. 2. Department of Pharmacy, University of Naples Federico II, Naples, Italy. 3. National Centre for Healthcare Research & Pharmacoepidemiology, at the University of Milano-Bicocca, Milan, Italy. 4. Department of Statistics and Quantitative Methods, Laboratory of Healthcare Research & Pharmacoepidemiology, Unit of Biostatistics, Epidemiology and Public Health, University of Milano-Bicocca, Milan, Italy. 5. Infectious Disease of Healthcare Direction, AORN Antonio Cardarelli, Naples, Italy. 6. Regional Pharmaceutical Unit, Campania Region, Naples, Italy. 7. Division of Cardiac Surgery, AOU San Giovanni di Dio e Ruggi d'Aragona, Salerno, Italy.
Abstract
BACKGROUND: The novel coronavirus (SARS-CoV-2) pandemic spread rapidly worldwide increasing exponentially in Italy. To date, there is lack of studies describing clinical characteristics of the people at high risk of infection. Hence, we aimed (i) to identify clinical predictors of SARS-CoV-2 infection risk, (ii) to develop and validate a score predicting SARS-CoV-2 infection risk, and (iii) to compare it with unspecific scores. METHODS: Retrospective case-control study using administrative health-related database was carried out in Southern Italy (Campania region) among beneficiaries of Regional Health Service aged over than 30 years. For each person with SARS-CoV-2 confirmed infection (case), up to five controls were randomly matched for gender, age and municipality of residence. Odds ratios and 90% confidence intervals for associations between candidate predictors and risk of infection were estimated by means of conditional logistic regression. SARS-CoV-2 Infection Score (SIS) was developed by generating a total aggregate score obtained from assignment of a weight at each selected covariate using coefficients estimated from the model. Finally, the score was categorized by assigning increasing values from 1 to 4. Discriminant power was used to compare SIS performance with that of other comorbidity scores. RESULTS: Subjects suffering from diabetes, anaemias, Parkinson's disease, mental disorders, cardiovascular and inflammatory bowel and kidney diseases showed increased risk of SARS-CoV-2 infection. Similar estimates were recorded for men and women and younger and older than 65 years. Fifteen conditions significantly contributed to the SIS. As SIS value increases, risk progressively increases, being odds of SARS-CoV-2 infection among people with the highest SIS value (SIS = 4) 1.74 times higher than those unaffected by any SIS contributing conditions (SIS = 1). CONCLUSION: Conditions and diseases making people more vulnerable to SARS-CoV-2 infection were identified by the current study. Our results support decision-makers in identifying high-risk people and adopting of preventive measures to minimize the spread of further epidemic waves.
BACKGROUND: The novel coronavirus (SARS-CoV-2) pandemic spread rapidly worldwide increasing exponentially in Italy. To date, there is lack of studies describing clinical characteristics of the people at high risk of infection. Hence, we aimed (i) to identify clinical predictors of SARS-CoV-2 infection risk, (ii) to develop and validate a score predicting SARS-CoV-2 infection risk, and (iii) to compare it with unspecific scores. METHODS: Retrospective case-control study using administrative health-related database was carried out in Southern Italy (Campania region) among beneficiaries of Regional Health Service aged over than 30 years. For each person with SARS-CoV-2 confirmed infection (case), up to five controls were randomly matched for gender, age and municipality of residence. Odds ratios and 90% confidence intervals for associations between candidate predictors and risk of infection were estimated by means of conditional logistic regression. SARS-CoV-2 Infection Score (SIS) was developed by generating a total aggregate score obtained from assignment of a weight at each selected covariate using coefficients estimated from the model. Finally, the score was categorized by assigning increasing values from 1 to 4. Discriminant power was used to compare SIS performance with that of other comorbidity scores. RESULTS: Subjects suffering from diabetes, anaemias, Parkinson's disease, mental disorders, cardiovascular and inflammatory bowel and kidney diseases showed increased risk of SARS-CoV-2 infection. Similar estimates were recorded for men and women and younger and older than 65 years. Fifteen conditions significantly contributed to the SIS. As SIS value increases, risk progressively increases, being odds of SARS-CoV-2 infection among people with the highest SIS value (SIS = 4) 1.74 times higher than those unaffected by any SIS contributing conditions (SIS = 1). CONCLUSION: Conditions and diseases making people more vulnerable to SARS-CoV-2 infection were identified by the current study. Our results support decision-makers in identifying high-risk people and adopting of preventive measures to minimize the spread of further epidemic waves.
Authors: Vittorio Maio; Elaine Yuen; Carol Rabinowitz; Daniel Louis; Masahito Jimbo; Andrea Donatini; Sabine Mall; Francesco Taroni Journal: J Health Serv Res Policy Date: 2005-10
Authors: Hui Xu; Jing Qian; Nina P Paynter; Xuehong Zhang; Brian W Whitcomb; Shelley S Tworoger; Kathryn M Rexrode; Susan E Hankinson; Raji Balasubramanian Journal: Stat Med Date: 2018-11-22 Impact factor: 2.373
Authors: Niklas W Andersson; Renee D Goodwin; Niels Okkels; Lea N Gustafsson; Farah Taha; Steve W Cole; Povl Munk-Jørgensen Journal: Int J Epidemiol Date: 2015-12-26 Impact factor: 7.196
Authors: Adrian D Haimovich; Neal G Ravindra; Stoytcho Stoytchev; H Patrick Young; Francis P Wilson; David van Dijk; Wade L Schulz; R Andrew Taylor Journal: Ann Emerg Med Date: 2020-07-21 Impact factor: 5.721
Authors: Laure Wynants; Ben Van Calster; Gary S Collins; Richard D Riley; Georg Heinze; Ewoud Schuit; Marc M J Bonten; Darren L Dahly; Johanna A A Damen; Thomas P A Debray; Valentijn M T de Jong; Maarten De Vos; Paul Dhiman; Maria C Haller; Michael O Harhay; Liesbet Henckaerts; Pauline Heus; Michael Kammer; Nina Kreuzberger; Anna Lohmann; Kim Luijken; Jie Ma; Glen P Martin; David J McLernon; Constanza L Andaur Navarro; Johannes B Reitsma; Jamie C Sergeant; Chunhu Shi; Nicole Skoetz; Luc J M Smits; Kym I E Snell; Matthew Sperrin; René Spijker; Ewout W Steyerberg; Toshihiko Takada; Ioanna Tzoulaki; Sander M J van Kuijk; Bas van Bussel; Iwan C C van der Horst; Florien S van Royen; Jan Y Verbakel; Christine Wallisch; Jack Wilkinson; Robert Wolff; Lotty Hooft; Karel G M Moons; Maarten van Smeden Journal: BMJ Date: 2020-04-07
Authors: Kevin Bliek-Bueno; Sara Mucherino; Beatriz Poblador-Plou; Francisca González-Rubio; Mercedes Aza-Pascual-Salcedo; Valentina Orlando; Mercedes Clerencia-Sierra; Ignatios Ioakeim-Skoufa; Enrico Coscioni; Jonás Carmona-Pírez; Alessandro Perrella; Ugo Trama; Alexandra Prados-Torres; Enrica Menditto; Antonio Gimeno-Miguel Journal: Int J Environ Res Public Health Date: 2021-11-10 Impact factor: 3.390
Authors: Antonia F Demleitner; Andreas W Wolff; Johanna Erber; Friedemann Gebhardt; Erica Westenberg; Andrea S Winkler; Susanne Kolbe-Busch; Iris F Chaberny; Paul Lingor Journal: J Neural Transm (Vienna) Date: 2022-03-04 Impact factor: 3.850
Authors: Felicia Ceban; Danica Nogo; Isidro P Carvalho; Yena Lee; Flora Nasri; Jiaqi Xiong; Leanna M W Lui; Mehala Subramaniapillai; Hartej Gill; Rene N Liu; Prianca Joseph; Kayla M Teopiz; Bing Cao; Rodrigo B Mansur; Kangguang Lin; Joshua D Rosenblat; Roger C Ho; Roger S McIntyre Journal: JAMA Psychiatry Date: 2021-10-01 Impact factor: 25.911